Jacobs Levy Equity Management
AGIO icon

Jacobs Levy Equity Management’s Agios Pharmaceuticals AGIO Stock Holding History

Jacobs Levy Equity Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$851K Sell
22,938
-5,592
-20% -$170K ﹤0.01% 735
2026
Q1 		$965K Sell
28,530
-82,620
-74% -$2.34M ﹤0.01% 714
2025
Q4 		$3.03M Buy
+111,150
New +$3.9M 0.01% 516
2023
Q3 		– Sell
-144,611
Closed -$4.1M – 955
2023
Q2 		$4.1M Sell
144,611
-469,922
-76% -$11.7M 0.02% 437
2023
Q1 		$14.1M Buy
614,533
+145,787
+31% +$3.87M 0.09% 236
2022
Q4 		$13.2M Sell
468,746
-17,980
-4% -$507K 0.09% 245
2022
Q3 		$13.8M Buy
486,726
+89,711
+23% +$2.41M 0.11% 207
2022
Q2 		$8.8M Sell
397,015
-68,837
-15% -$1.55M 0.07% 303
2022
Q1 		$13.6M Buy
465,852
+157,811
+51% +$4.82M 0.09% 242
2021
Q4 		$10.1M Buy
308,041
+5,494
+2% +$221K 0.07% 302
2021
Q3 		$14M Buy
302,547
+84,525
+39% +$4.08M 0.09% 242
2021
Q2 		$12M Buy
218,022
+14,746
+7% +$825K 0.08% 258
2021
Q1 		$10.5M Buy
203,276
+86,690
+74% +$4.29M 0.08% 287
2020
Q4 		$5.05M Sell
116,586
-19,701
-14% -$779K 0.04% 396
2020
Q3 		$4.77M Buy
136,287
+92,090
+208% +$4.04M 0.05% 350
2020
Q2 		$2.36M Buy
+44,197
New +$2.05M 0.03% 496
2018
Q1 		– Sell
-15,500
Closed -$886K – 992
2017
Q4 		$886K Buy
+15,500
New +$975K 0.02% 640
2016
Q4 		– Sell
-78,537
Closed -$4.15M – 951
2016
Q3 		$4.15M Buy
78,537
+45,347
+137% +$1.97M 0.07% 295
2016
Q2 		$1.39M Buy
+33,190
New +$1.64M 0.03% 500

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Jacobs Levy Equity Management's AGIO Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its Agios Pharmaceuticals (AGIO) stake by 20% in Q2 2026, selling an estimated $170K and leaving 22,938 shares worth $851K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

Jacobs Levy Equity Management first reported a position in AGIO in Q2 2016 and has held it in 19 quarters since. The position peaked at $14.1M in Q1 2023. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Jacobs Levy Equity Management held 22,938 shares of Agios Pharmaceuticals worth $851K as of Q2 2026.
  • Jacobs Levy Equity Management sold 5,592 Agios Pharmaceuticals shares in Q2 2026, an estimated $170K.
  • Agios Pharmaceuticals made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #735 holding.
  • Jacobs Levy Equity Management first reported a position in Agios Pharmaceuticals in Q2 2016 and has held it in 19 quarters since.
  • Jacobs Levy Equity Management's Agios Pharmaceuticals position peaked at $14.1M in Q1 2023.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.